Matías Nicolás Bossa

Matías Nicolás Bossa

Auto-generated profile, based on publicly available information

Matías Nicolás Bossa

Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel (VUB), Brussels, Belgium

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2009 in International Journal of Computer Vision
Verified
Journal Article
Closed access
PDF file
MHMonica Hernandez
Monica Hernandez
MBMatias N. Bossa
Matias N. Bossa
SOSalvador Olmos
Salvador Olmos

31 December 2006
Verified
Book Chapter
Closed access
PDF file
MBMatias Bossa
Matias Bossa
MHMonica Hernandez
Monica Hernandez
SOSalvador Olmos
Salvador Olmos



23 February 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MBMatías Nicolás Bossa
Matías Nicolás Bossa
HSHichem Sahli
Hichem Sahli
Data-driven Alzheimer’s disease (AD) progression models are useful for clinical prediction, disease mechanism understanding, and clinical trial design. Most dynamic models were inspired by the amyloid cascade hypothesis and described AD progression as a linear chain of pathological events. However, the heterogeneity observed in healthy and sporadic AD populations challenged the amyloid hypothesis, and there is a need for more flexible dynamical models that accompany this conceptual shift. We present a statistical model of the temporal evolution of biomarkers and cognitive tests that allows diverse biomarker paths throughout the disease. The model consists of two elements: a multivariate dynamic model of the joint evolution of biomarkers and cognitive tests; and a clinical prediction model. The dynamic model uses a system of ordinary differential equations to jointly model the rate of change of an individual’s biomarkers and cognitive tests. The clinical prediction model is an ordinal logistic model of the diagnostic label. Prognosis and time-to-onset predictions are obtained by computing the clinical label probabilities throughout the forecasted biomarker trajectories. The proposed dynamical model is interpretable, free of one-dimensional progression hypotheses or disease staging paradigms, and can account for the heterogeneous dynamics observed in sporadic AD. We developed the model using longitudinal data from the Alzheimer’s Disease Neuroimaging Initiative. We illustrate the patterns of biomarker rates of change and the model performance to predict the time to conversion from MCI to dementia.

21 February 2024 in Medical Image Analysis
Verified
Journal Article
Closed access
ABAbel Díaz Berenguer
Abel Díaz Berenguer
MKMaryna Kvasnytsia
Maryna Kvasnytsia
MBMatías Nicolás Bossa
Matías Nicolás Bossa
TMTanmoy Mukherjee
Tanmoy Mukherjee
NDNikos Deligiannis
Nikos Deligiannis
HSHichem Sahli
Hichem Sahli